- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2859
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Purification of a chimeric virus-like particle from a complex culture medium ; volume:5 ; number:1 ; day:10 ; month:10 ; year:2006 ; pages:1-3 ; date:10.2006
Microbial cell factories ; 5, Heft 1 (10.10.2006), 1-3, 10.2006
- Creator
-
Pedro, Luísa
- Contributor
-
Ferreira, Guilherme NM
SpringerLink (Online service)
- DOI
-
10.1186/1475-2859-5-S1-P95
- URN
-
urn:nbn:de:1111-2016072546029
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pedro, Luísa
- Ferreira, Guilherme NM
- SpringerLink (Online service)
Other Objects (12)
Advancing usability of an influenza hemagglutinin virus-like particle vaccine expressing a chimeric cytokine
Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates
A chimeric MERS-CoV virus-like particle vaccine protects mice against MERS-CoV challenge
Cost‐effective purification process development for chimeric hepatitis B core (HBc) virus‐like particles assisted by molecular dynamic simulation
At‐line multi‐angle light scattering detector for faster process development in enveloped virus‐like particle purification
Virus-like particle vaccinology, from bench to bedside
Construction, purification, and characterization of a chimeric TH1 antagonist
Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness
Thermally-responsive Virus-like Particle for Targeted Delivery of Cancer Drug
Design of hepadnavirus core protein-based chimeric virus-like particles carrying epitopes from respiratory syncytial virus
Bacterial superglue enables easy development of efficient virus-like particle based vaccines
Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity
Advancing usability of an influenza hemagglutinin virus-like particle vaccine expressing a chimeric cytokine
Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates
A chimeric MERS-CoV virus-like particle vaccine protects mice against MERS-CoV challenge
Cost‐effective purification process development for chimeric hepatitis B core (HBc) virus‐like particles assisted by molecular dynamic simulation
At‐line multi‐angle light scattering detector for faster process development in enveloped virus‐like particle purification
Virus-like particle vaccinology, from bench to bedside
Construction, purification, and characterization of a chimeric TH1 antagonist
Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness
Thermally-responsive Virus-like Particle for Targeted Delivery of Cancer Drug
Design of hepadnavirus core protein-based chimeric virus-like particles carrying epitopes from respiratory syncytial virus
Bacterial superglue enables easy development of efficient virus-like particle based vaccines
Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity
Advancing usability of an influenza hemagglutinin virus-like particle vaccine expressing a chimeric cytokine
Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates
A chimeric MERS-CoV virus-like particle vaccine protects mice against MERS-CoV challenge
Cost‐effective purification process development for chimeric hepatitis B core (HBc) virus‐like particles assisted by molecular dynamic simulation
At‐line multi‐angle light scattering detector for faster process development in enveloped virus‐like particle purification
Virus-like particle vaccinology, from bench to bedside
Construction, purification, and characterization of a chimeric TH1 antagonist
Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness
Thermally-responsive Virus-like Particle for Targeted Delivery of Cancer Drug
Design of hepadnavirus core protein-based chimeric virus-like particles carrying epitopes from respiratory syncytial virus
Bacterial superglue enables easy development of efficient virus-like particle based vaccines